Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[RNA pathologies in neurological disorders].

Kinji Ohno1

  • 1Division of Neurogenetics and Bioinformatics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|January 24, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review of Congenital Myasthenic Syndrome Caused by Pathogenic Variants in GFPT1.

Muscle & nerve·2026
Same author

A Preliminary Open-Label Pilot Study of a Pillow-Based ELF-ELME (Extremely Low-Frequency, Extremely Low Magnetic Environment) Intervention for Major Depressive Disorder.

Neuropsychopharmacology reports·2026
Same author

Respiratory-physiology modeling of therapeutic hydrogen inhalation: defining the fraction of inspired hydrogen (FiH<sub>2</sub>) and flow-rate requirements.

Respiratory research·2026
Same author

Bacterial constipation: Mucin-degrading intestinal commensal bacteria cause constipation.

Gut microbes·2026
Same author

Piper rhythm-like electromyographical activity in muscle stiffness in sodium channel myotonia representing potassium-aggravated myotonia and myotonia permanens.

Journal of neurophysiology·2025
Same author

The Rieske iron-sulfur protein is a primary target of molecular hydrogen.

Redox biology·2025
Same journal

[Utility of acute-phase cerebral blood flow single photon emission computed tomography (SPECT) for evaluating the pathophysiology of Bickerstaff brainstem encephalitis with decorticate posturing].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Successful treatment with rituximab in unilateral relapsing primary CNS vasculitis: a ‍case report].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Clinical management of headache comorbid with functional neurological disorder].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Transient myoclonic state with asterixis related to COVID-19].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Let's present at a regional meeting].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Editor's Note].

Rinsho shinkeigaku = Clinical neurology·2026
See all related articles

Aberrant RNA splicing significantly contributes to numerous neurological disorders. This review explores RNA pathologies and potential RNA-targeting therapies for conditions like Parkinson's and Alzheimer's disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Context:

  • RNA's role extends beyond protein synthesis, encompassing regulatory functions via non-coding and small RNAs.
  • Alternative splicing generates protein diversity, crucial for tissue-specific and developmental processes.
  • The human genome's limited gene count underscores the importance of post-transcriptional regulation.

Purpose:

  • To review the significant role of RNA pathologies, particularly aberrant splicing, in neurological disorders.
  • To highlight specific neurological conditions causally linked to RNA splicing defects.
  • To discuss emerging RNA-targeting therapeutic strategies for these diseases.

Summary:

  • Focuses on aberrant splicing events and their pathological alterations in splicing cis- and trans-elements.

Related Experiment Videos

  • Details neurological disorders associated with RNA pathologies, including congenital myasthenic syndromes, Parkinson's disease, Alzheimer's disease, and others.
  • Explores potential RNA-based therapeutic interventions for conditions such as Duchenne muscular dystrophy and spinal muscular atrophy.

    • Impact:

    • Enhances understanding of RNA's complex role in neurological health and disease.
    • Provides a comprehensive overview of RNA-related neurological disorders for researchers and clinicians.
    • Identifies promising avenues for developing novel RNA-targeted therapies for currently intractable neurological conditions.